Works matching IS 0307-6938 AND VI 47 AND IP 3 AND DT 2022

Results: 46

Mentorship in dermatology: a necessity in difficult times.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 622, doi. 10.1111/ced.15071

By:

Hussain, Khawar;
Patel, Neil;
Fearfield, Louise;
Roberts, Nerys;
Staughton, Richard

Publication type:

Article

Gaining access to treatment; life at the far side of atopic eczema.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 624, doi. 10.1111/ced.15053

By:

Dolan, M.;
Blake, C.;
Cosgrave, N.;
McMahon, D.;
Greenwood, M.;
Tobin, A.‐M.

Publication type:

Article

PAPA‐like syndrome with heterozygous mutation in the MEFV gene.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 642, doi. 10.1111/ced.15027

By:

O'Connor, C.;
Kiely, L.;
Heffron, C.;
Ryan, J.;
Bennett, M.

Publication type:

Article

A rare case of lipase hypersecretion syndrome.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 635, doi. 10.1111/ced.15023

By:

Sofela, J.;
Hunt, W. T. N.;
Chaytor, R.;
Stephens, M.;
Sofela, A.;
Harmse, D.;
Chave, T.

Publication type:

Article

A detailed regimen of isotretinoin for the successful treatment of severe keratosis pilaris.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 619, doi. 10.1111/ced.15020

By:

Kirchner, A.;
Hoyer, S.

Publication type:

Article

Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 608, doi. 10.1111/ced.15018

By:

Gambichler, T.;
Hessam, S.;
Lüttringhaus, T.;
Boms, S.

Publication type:

Article

Consulting 'Dr YouTube': a content analysis of YouTube<sup>®</sup> videos related to hidradenitis suppurativa treatments.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 606, doi. 10.1111/ced.15017

By:

Lukac, D.;
Pagani, K.;
Yi, J. Z.;
McGee, J. S.

Publication type:

Article

Risankizumab‐induced paradoxical pustular psoriasis.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 616, doi. 10.1111/ced.15006

By:

McFeely, O.;
Pender, E.;
Victory, L.;
Almutlaq, H.;
Storan, E.

Publication type:

Article

Phenotypic spectrum of serious cutaneous‐only adverse event following immunization with COVID‐19 vaccines: a multicentre case series and literature review.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 614, doi. 10.1111/ced.15003

By:

Balogun, M.;
Millette, D.;
Yip, V.;
Chan, S. A.;
Lee, P.;
Gamal, N.;
Hashim, N.;
Phillips, D.;
Walsh, M.;
Trehan, P.;
Hanna‐Bashara, L.;
Abdullah, A.;
Wernham, A.;
Tso, S.

Publication type:

Article

Erythema annulare centrifugum induced by COVID‐19 vaccination.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 591, doi. 10.1111/ced.15002

By:

Kim, J. C.;
Lee, S. Y.;
Kang, S. Y.;
Kim, H. O.;
Park, C. W.;
Chung, B. Y.

Publication type:

Article

'Your mascara is running'.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 639, doi. 10.1111/ced.15015

By:

Kelly, A.;
Gandhi, R.;
Natkunarajah, J.

Publication type:

Article

Muir–Torre syndrome: a case of unusual coexisting genetic mutations.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 602, doi. 10.1111/ced.15008

By:

Cino, D.;
Drumm, C.;
Sheahan, K.;
D'Arcy, C.;
Nolan, N.;
Hoti, E.;
Winter, D.;
O'Duffy, F.;
Dolan, R.;
Moriarty, B.

Publication type:

Article

Linear IgA bullous dermatosis following Oxford AstraZeneca COVID‐19 vaccine.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 611, doi. 10.1111/ced.15007

By:

Hali, F.;
Kerouach, A.;
Alatawna, H.;
Chiheb, S.;
Lakhdar, H.

Publication type:

Article

Scurvy in a patient with thalassaemia.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 613, doi. 10.1111/ced.15014

By:

Maikap, D.;
Padhan, P.

Publication type:

Article

Skin abscesses, X‐linked agammaglobulinaemia and spastic paraplegias in a male patient.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 617, doi. 10.1111/ced.15013

By:

Zhang, C. C.;
Chen, Z. M.;
Chen, H.

Publication type:

Article

Annular plaques on the back.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 632, doi. 10.1111/ced.15011

By:

Pruessmann, J. N.;
Shimanovich, I.;
Langan, E. A.;
Zillikens, D.;
Ludwig, R. J.;
Boch, K.

Publication type:

Article

Comparison of cost changes due to the COVID‐19 pandemic for Dermatology residency applications in the USA.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 600, doi. 10.1111/ced.15001

By:

Gorgy, M.;
Shah, S.;
Arbuiso, S.;
Cline, A.;
Russo, M.

Publication type:

Article

Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 604, doi. 10.1111/ced.15000

By:

Zengarini, C.;
Roda, M.;
Schiavi, C.;
Bruni, F.;
Bardazzi, F.;
Bellusci, C.;
Raone, B.

Publication type:

Article

Successful use of tofacitinib in epidermolysis bullosa pruriginosa.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 598, doi. 10.1111/ced.14998

By:

Chen, K.‐J.;
Fang, S.;
Ye, Q.;
Jia, M.

Publication type:

Article

Cutaneous larva migrans: an unusual souvenir from a Scottish holiday.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 593, doi. 10.1111/ced.14996

By:

Paget, S.;
Fernandez, C.;
Zaheri, S.

Publication type:

Article

Ulcerating nodules on the face due to Mycobacterium chimaera in a patient with diabetes.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 587, doi. 10.1111/ced.14993

By:

George, M.;
Afra, T. P.;
Santhosh, P.;
Nandakumar, G.;
Balagopalan, D.;
Sreedharan, S.

Publication type:

Article

The virtual Men's Shed: a pilot of online access to skin cancer education for a high‐risk population during the COVID‐19 pandemic.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 595, doi. 10.1111/ced.14992

By:

Lynch, L.;
O'Connor, C.;
Bennett, M.;
Murphy, M.

Publication type:

Article

Tinea capitis by Microsporum canis in a 3‐year‐old girl with palmoplantar pustular dermatophytid reaction.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 596, doi. 10.1111/ced.14991

By:

el Imene Ouni, N.;
Aounallah, A.;
Ghariani, N.;
Mokni, S.;
Belajouza, C.;
Denguezli, M.

Publication type:

Article

Evaluating paediatric dermatology telephone clinics during COVID‐19 from a dual clinician and patient perspective: a prospective study.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 553, doi. 10.1111/ced.14990

By:

Lowe, A.;
Dawood, S.;
Al‐Tayeb, A.;
Hancock, P.;
Pararajasingam, A.;
Ali, F.;
Goodwin, R. G.

Publication type:

Article

Can distant teaching replace face‐to‐face dermatology education in general medicine?

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 597, doi. 10.1111/ced.14989

By:

Idoudi, S.;
Duru, G.;
Eberhardt, A.;
Thomas, L.

Publication type:

Article

The human microbiome in immunobullous disorders and lichen planus.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 522, doi. 10.1111/ced.14987

By:

Karimova, M.;
Moyes, D.;
Ide, M.;
Setterfield, J. F.

Publication type:

Article

Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 592, doi. 10.1111/ced.14984

By:

Raimondo, A.;
Guglielmi, G.;
Marino, C.;
Ligrone, L.;
Lembo, S.

Publication type:

Article

Anagen effluvium and the role of trichoscopy.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 589, doi. 10.1111/ced.14982

By:

Starace, M.;
Orlando, G.;
Bruni, F.;
Alessandrini, A.;
Piraccini, B. M.

Publication type:

Article

Sustainable dermatology: a service review at Warwick and quality improvement initiatives.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 584, doi. 10.1111/ced.14981

By:

Mann, S.;
Sebastian, N.;
Okonji, E.;
Tso, V. B. Y.;
Thind, C.;
Unter, S.;
Gee, B. C.;
Bedlow, A. J.;
Carter, J. J.;
Eykyn, H.;
Williamson, T.;
Barrass, S.;
Tso, S.

Publication type:

Article

A serpiginous eruption.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 629, doi. 10.1111/ced.14980

By:

Carey, S.;
Salisbury, J.;
Rudd, E.;
Courtney, K.;
Berovic, M.;
Walsh, S.

Publication type:

Article

Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 561, doi. 10.1111/ced.14979

By:

Ruggiero, A.;
Fabbrocini, G.;
Cinelli, E.;
Ocampo Garza, S. S.;
Camela, E.;
Megna, M.

Publication type:

Article

Issues surrounding consumer‐bought food‐allergy testing.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 547, doi. 10.1111/ced.14978

By:

Wong, A. W. Y.;
White, H. E. G.;
Plant, A.;
Shipman, A. R.;
Shipman, K. E.

Publication type:

Article

Koebner phenomenon seen in a case of drug‐induced granular C3 dermatosis.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 609, doi. 10.1111/ced.14977

By:

Ohata, M.;
Fukumoto, T.;
Hashimoto, T.;
Takemori, C.;
Jimbo, H.;
Nagai, H.;
Oka, M.;
Nishigori, C.

Publication type:

Article

Deceleration in the rate of keratinocyte cancers and precancerous lesions during programmed death‐1 inhibition therapy for advanced melanoma, with recrudescence on discontinuation.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 582, doi. 10.1111/ced.14974

By:

Roche, L.;
Moriarty, B.;
Fabre, A.;
Crowne, J.;
Lally, A.

Publication type:

Article

Propylthiouracil‐induced vasculitis presenting as purpuric plaques on cheeks.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 581, doi. 10.1111/ced.14973

By:

Wada, S.;
Namiki, T.;
Miura, K.;
Miyazaki, Y.

Publication type:

Article

Perceptions of the use of artificial intelligence in the diagnosis of skin cancer: an outpatient survey.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 542, doi. 10.1111/ced.14969

By:

Lim, K.;
Neal‐Smith, G.;
Mitchell, C.;
Xerri, J.;
Chuanromanee, P.

Publication type:

Article

A rare mimic of basal cell carcinoma.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 626, doi. 10.1111/ced.14963

By:

Kamp, E.;
Musbahi, E.;
Graham, G.;
Ascott, A.;
Nardini, N.;
Calonje, E.;
Topham, E.

Publication type:

Article

Topical Cyperus rotundus essential oil for treatment of axillary hyperpigmentation: a randomized, double‐blind, active‐ and placebo‐controlled study.

Published in:: Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 534, doi. 10.1111/ced.14959
Publication type:: Article

Cysteamine as a topical management option for melasma.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 646, doi. 10.1111/ced.14958

By:

Hira, S. K.;
Nalluri, R.

Publication type:

Article

Novel targets and therapies for keloid.

Published in:: Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 507, doi. 10.1111/ced.14920
Publication type:: Article

Influence of COVID‐19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 578, doi. 10.1111/ced.14957

By:

Conde‐Taboada, A.;
Iglesias‐Puzas, Á.;
Sirgado, A.;
Campos, L.;
Serrano, I.;
López‐Bran, E.

Publication type:

Article

Favipiravir‐induced cutaneous adverse reactions in patients infected with COVID‐19.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 573, doi. 10.1111/ced.14953

By:

Punyaratabandhu, P.;
Vanitchpongphan, S.

Publication type:

Article

'Rainbow pattern': a dermoscopic sign of invasive melanoma.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 529, doi. 10.1111/ced.14950

By:

Rodríguez‐Lomba, E.;
García‐Piqueras, P.;
Lozano‐Masdemont, B.;
Nieto‐Benito, L. M.;
Hernández de la Torre, E.;
Parra‐Blanco, V.;
Suárez‐Fernández, R.;
Lázaro‐Ochaita, P.;
Avilés‐Izquierdo, J. A.

Publication type:

Article

Percutaneous ethanol sclerotherapy is a promising treatment for recalcitrant angiolymphoid hyperplasia with eosinophilia.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 568, doi. 10.1111/ced.14940

By:

Galili, E.;
Levi, A.;
Lapidoth, M.;
Barzilai, A.;
Hodak, E.;
Rimon, U.

Publication type:

Article

Issue Information.

Published in:: Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 505, doi. 10.1111/ced.14735
Publication type:: Article

Treatment options for leishmaniasis.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 516, doi. 10.1111/ced.14919

By:

Pradhan, S.;
Schwartz, R.A.;
Patil, A.;
Grabbe, S.;
Goldust, M.

Publication type:

Article